New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
BioStem Technologies, Inc. (BSEM) vs Pluri Inc. (PLUR)
- BioStem Technologies, Inc. BSEM 0.64 −9.86%
- Pluri Inc. PLUR 0.94 −3.09%
BioStem Technologies, Inc. and Pluri Inc. are both Biotechnology companies. BioStem Technologies, Inc. and Pluri Inc. are of similar size ($13.9M and $13.6M). Pluri Inc. grew revenue faster over the last twelve months: 10.0% against −83.9%. BioStem Technologies, Inc. has the higher net margin (−121.0% vs −1,943.9%) and the higher return on invested capital (−7.07% vs −436.8%). Across the 11 metrics below, BioStem Technologies, Inc. leads on 7 and Pluri Inc. on 4.
Valuation
Profitability
| Metric | BSEM | PLUR | Biotechnology median |
|---|---|---|---|
| Gross margin | 79.83% | 51.95% | 70.18% |
| Operating margin | (6.18%) | (2,341.12%) | 0.00% |
| Net margin | (121.02%) | (1,943.87%) | 0.00% |
| Free cash flow margin | — | (1,316.52%) | 0.00% |
| Return on equity | — | 253.49% | (51.58%) |
| Return on assets | — | (96.79%) | (45.91%) |
| Return on invested capital | (7.07%) | (436.83%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack